Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Nu-Med Plus | - | - | - | 53.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.65% |
| Sep 30, 2025 | 61.46% |
| Jun 30, 2025 | 34.99% |
| Mar 31, 2025 | 8.10% |
| Dec 31, 2024 | 83.22% |
| Sep 30, 2024 | -14.99% |
| Jun 30, 2024 | 30.48% |
| Mar 31, 2024 | 24.56% |
| Dec 31, 2020 | -363.61% |
| Sep 30, 2020 | -230.07% |
| Jun 30, 2020 | -507.68% |
| Mar 31, 2020 | -139.23% |
| Dec 31, 2019 | -169.17% |
| Sep 30, 2019 | -130.68% |
| Jun 30, 2019 | 59.05% |
| Mar 31, 2019 | 229.15% |
| Dec 31, 2018 | 109.14% |
| Sep 30, 2018 | 314.61% |
| Jun 30, 2018 | 48.70% |
| Mar 31, 2018 | 60.95% |
| Dec 31, 2017 | -156.56% |
| Sep 30, 2017 | -78.95% |
| Jun 30, 2017 | -27.41% |
| Mar 31, 2017 | 50.13% |
| Dec 31, 2016 | 780.99% |
| Sep 30, 2016 | 65.45% |
| Jun 30, 2016 | -67.11% |
| Mar 31, 2016 | -60.66% |
| Dec 31, 2015 | -253.04% |
| Sep 30, 2015 | 26.97% |
| Jun 30, 2015 | 96.31% |
| Mar 31, 2015 | 485.44% |
| Sep 30, 2014 | 3,590.74% |
| Jun 30, 2014 | 308.18% |
| Mar 31, 2014 | -86.25% |